Narrow-Band UVB Therapy and Topical Calcineurin Inhibitors for the Treatment of Paediatric Vitiligo in Real Clinical Practice
, , , , und
22. Juli 2021
Über diesen Artikel
Online veröffentlicht: 22. Juli 2021
Seitenbereich: 200 - 205
Eingereicht: 15. Juli 2020
Akzeptiert: 24. Jan. 2021
DOI: https://doi.org/10.2478/prolas-2021-0029
Schlüsselwörter
© 2020 Ilona Hartmane et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Hartmane, Ilona
Clinical Centre of Skin and Sexually Transmitted Diseases, Rīga 1st HospitalLatvia
Department of Dermatology and Venerology, Rīga Stradiņš UniversityLatvia
Mikažāns, Ingmārs
Clinical Centre of Skin and Sexually Transmitted Diseases, Rīga 1st HospitalLatvia
Department of Dermatology and Venerology, Rīga Stradiņš UniversityLatvia
Ivdra, Iveta
Clinical Centre of Skin and Sexually Transmitted Diseases, Rīga 1st HospitalLatvia
Department of Dermatology and Venerology, Rīga Stradiņš UniversityLatvia
Mirzajanova, Irēna
Department of Pharmacology, Rīga Stradiņš UniversityLatvia
UAB Johnson & Johnson Latvian branchLatvia
Dērveniece, Andra
Clinical Centre of Skin and Sexually Transmitted Diseases, Rīga 1st HospitalLatvia
Department of Dermatology and Venerology, Rīga Stradiņš UniversityLatvia
Bondare-Ansberga, Vanda
Clinical Centre of Skin and Sexually Transmitted Diseases, Rīga 1st HospitalLatvia